---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-093914"
form_type: "8-K"
ticker: "BEAM"
cik: "0001745999"
company_name: "Beam Therapeutics Inc."
filed_at: "2026-03-05T23:59:59+00:00"
generated_at: "2026-05-15T19:46:30.987619+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Beam terminates license pact with Bio Palette; Kobe University standby license activated

## Summary
- Mutual termination of License Agreement with Bio Palette effective March 2, 2026 due to Bio Palette's planned dissolution.
- Standby License Agreement with Kobe University activated, granting Beam exclusive license to base editing patents previously covered.
- No future payments due between Beam and Bio Palette under the Termination Agreement or License Agreement.
- Beam retains rights to exploit base editing technology for human disease worldwide, minus microbiome field in Asia.

## SEC filing metadata
- accession: 0001193125-26-093914
- form_type: 8-K
- ticker: BEAM
- cik: 0001745999
- company_name: Beam Therapeutics Inc.
- filed_at: 2026-03-05T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1745999/000119312526093914/0001193125-26-093914-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1745999/000119312526093914/beam-20260302.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-093914
- JSON: https://secwatch.observer/filing/0001193125-26-093914.json
- Plain text: https://secwatch.observer/filing/0001193125-26-093914.txt

## Key facts
- Material Agreements
  Beam Therapeutics Inc. terminated License Agreement with Bio Palette Co., Ltd. (effective 2026-03-02).
  - Action: termination
  - Agreement: license
  - Counterparty: Bio Palette Co., Ltd.
  - Effective: 2026-03-02
  source text: Beam Therapeutics Inc. (the “Company”) and Bio Palette Co., Ltd. (“Bio Palette”) mutually terminated the License Agreement by and between the Company and Bio Palette dated March 27, 2019 (the “License Agreement”)
  evidence_url: https://www.sec.gov/Archives/edgar/data/1745999/000119312526093914/0001193125-26-093914-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.